Skip to main content

Table 2 Characteristics of participants based on disease activity a

From: Does the inflammatory potential of diet affect disease activity in patients with inflammatory bowel disease?

 

Total

(n = 143)

Inactive

(n = 79)

Active

(n = 64)

P value

Age, years

38.7 ± 10.8

37.9 ± 11.2

39.7 ± 10.3

0.32

Female, n (%)

66 (46.2)

38 (48.1)

28 (43.8)

0.62

BMI, kg/m2

25.0 ± 3.03

25.3 ± 3.21

24.6 ± 2.78

0.19

Smokers, n (%)

22 (15.4)

11 (13.9)

11 (17.2)

0.64

Education, n (%)

 < 14 years of formal education

26 (18.2)

18 (22.8)

8 (12.5)

0.21

 Bachelor’s degree

73 (51.0)

36 (45.6)

37 (57.8)

 ≥ Master’s degree

44 (30.8)

25 (31.6)

19 (29.7)

IBD Type, n (%)

 Crohn’s disease

32 (22.4)

11 (13.9)

21 (32.8)

0.006

 Ulcerative colitis

111 (77.6)

68 (86.1)

43 (67.2)

 

Disease activity, Median (min, max)

 Crohn’s disease activity index

193 (65.0,400)

80.0(65.0, 145)

250 (155, 400)

 

 Mayo score for Ulcerative colitis

1.0 (0, 11.0)

1.0 (0, 2.0)

8.0 (4.0, 11.0)

 

IBD-related drug consumption, n (%)

 No drugs

6 (4.20)

3 (3.80)

3 (4.70)

0.001

 Single drugsb

42 (29.4)

33 (41.8)

9 (14.1)

 Multiple drugsc

95 (66.4)

43 (54.5)

52 (81.2)

Dietary intakes

 Energy (kcal/d)

2021 ± 326

2062 ± 354

1971 ± 282

0.09

 Carbohydrate (% of energy)

62.4 ± 4.16

62.2 ± 4.77

62.8 ± 3.26

0.40

 Fat (% of energy)

26.2 ± 3.60

26.4 ± 4.10

26.0 ± 2.89

0.51

 Protein (% of energy)

14.2 ± 1.38

14.3 ± 1.56

14.1 ± 1.11

0.46

 Saturated fatty acids (g/d)

17.6 ± 4.57

18.3 ± 4.94

17.0 ± 3.95

0.06

 Monounsaturated fatty acids (g/d)

21.5 ± 4.61

22.0 ± 5.32

21.0 ± 3.5

0.23

 Polyunsaturated fatty acids (g/d)

12.7 ± 2.61

12.8 ± 2.95

12.6 ± 2.11

0.65

 Grains (g/d)

497 ± 167

505 ± 200

487 ± 112

0.52

 Legumes (g/d)

13.2 ± 14.0

13.2 ± 14.7

13.3 ± 13.2

0.96

 Meats (g/d)

64.2 ± 28.8

66.9 ± 33.8

60.8 ± 20.9

0.21

 Dairy products (g/d)

233 ± 155

251 ± 162

297 ± 89.3

0.12

 Fruits (g/d)

293 ± 78.1

297 ± 89.3

288 ± 61.7

0.51

 Vegetables (g/d)

191 ± 48.7

190 ± 53.7

193 ± 42.1

0.72

 Fast foods (g/d)

13.9 ± 15.1

14.6 ± 18.4

13.0 ± 9.67

0.53

Diet inflammatory scores

 DII

−1.59 ± 1.24

−1.21 ± 1.24

−1.45 ± 1.04

0.23

 EDIP

0.54 ± 0.25

0.53 ± 0.28

0.56 ± 0.22

0.54

  1. aData are presented as mean ± SDs unless otherwise stated.b Consumption of aminosalicylic acid compounds (5-ASA) or immune modulators, i.e. azathioprine, prednisolone and methotrexate, each per se.c Combination at least two classes of drugs, including ASA, immune modulator, and anti-tumor necrosis factor (TNF) agents, i.e., Remicade® infliximab and Humira® (adalimumab). BMI Body mass index, DII Dietary inflammatory index inflammatory bowel disease, EDIP Empirically derived inflammatory pattern, IBD Inflammatory bowel disease